Inventor
CHATTERTON JON E
US54 patents
⚠️ This page may combine multiple inventors who share the name “CHATTERTON JON E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARROWHEAD RES CORP
15 patentsUS9289514B2Mar 22, 2016
Low density lipoprotein receptor-mediated siRNA delivery
ARROWHEAD RES CORP4 citations84
US9562230B2Feb 7, 2017
Transferrin/transferrin receptor-mediated siRNA delivery
ARROWHEAD RES CORP1 citations63
US9526799B2Dec 27, 2016
Low density lipoprotein receptor-mediated siRNA delivery
ARROWHEAD RES CORP2 citations63
US9233170B2Jan 12, 2016
Interfering RNA delivery system and uses thereof
ARROWHEAD RES CORP1 citations63
US9206428B2Dec 8, 2015
RNAi-mediated inhibition of histamine receptor H1-related conditions
ARROWHEAD RES CORP2 citations63
US9476047B2Oct 25, 2016
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
ARROWHEAD RES CORP1 citations62
US9795684B2Oct 24, 2017
Interfering RNA delivery system and uses thereof
ARROWHEAD RES CORP0 citations52
US9745585B2Aug 29, 2017
RNAi-mediated inhibition of histamine receptor H1-related conditions
ARROWHEAD RES CORP0 citations52
US9371529B2Jun 21, 2016
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
ARROWHEAD RES CORP0 citations52
US9347062B2May 24, 2016
Interfering RNA delivery system and uses thereof
ARROWHEAD RES CORP0 citations52
US9114152B2Aug 25, 2015
Transferrin/transferrin receptor-mediated siRNA delivery
ARROWHEAD RES CORP0 citations52
US9550994B2Jan 24, 2017
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
ARROWHEAD RES CORP0 citations51
US9447419B2Sep 20, 2016
RNAi-mediated inhibition of tumor necrosis factor α-related conditions
ARROWHEAD RES CORP0 citations51
US9422556B2Aug 23, 2016
RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis
ARROWHEAD RES CORP0 citations50
US9139834B2Sep 22, 2015
RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
ARROWHEAD RES CORP0 citations50
CHATTERTON JON E
9 patentsUS8268798B2Sep 18, 2012
Low density lipoprotein receptor-mediated siRNA delivery
CHATTERTON JON E34 citations96
US8664375B2Mar 4, 2014
Interfering RNA delivery system and uses thereof
CHATTERTON JON E4 citations84
US8399653B2Mar 19, 2013
Transferrin/transferrin receptor-mediated siRNA delivery
CHATTERTON JON E8 citations84
US8569258B2Oct 29, 2013
Low density lipoprotein receptor-mediated siRNA delivery
CHATTERTON JON E1 citations62
US8168609B2May 1, 2012
RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders
CHATTERTON JON E0 citations52
US9173896B2Nov 3, 2015
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
CHATTERTON JON E0 citations51
US8471000B2Jun 25, 2013
RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
CHATTERTON JON E0 citations51
US8865670B2Oct 21, 2014
RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma
CHATTERTON JON E0 citations50
US8754202B2Jun 17, 2014
RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis
CHATTERTON JON E0 citations50
ALCON RES LTD
8 patentsUS8940887B2Jan 27, 2015
RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
ALCON RES LTD31 citations93
US7973019B1Jul 5, 2011
Transferrin/transferrin receptor-mediated siRNA delivery
ALCON RES LTD16 citations93
US7879813B2Feb 1, 2011
Interfering RNA delivery system and uses thereof
ALCON RES LTD16 citations92
US8937051B2Jan 20, 2015
Low density lipoprotein receptor-mediated siRNA delivery
ALCON RES LTD3 citations74
US8017592B2Sep 13, 2011
RNAi-mediated inhibition of histamine receptor H1-related conditions
ALCON RES LTD5 citations74
US8048863B2Nov 1, 2011
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
ALCON RES LTD3 citations63
US7981870B2Jul 19, 2011
RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis
ALCON RES LTD2 citations62
US7732421B2Jun 8, 2010
RNAI-mediated inhibition of tumor necrosis factor α-related conditions
ALCON RES LTD4 citations62
YANNI JOHN M
5 patentsUS8222227B2Jul 17, 2012
RNAi-mediated inhibition of histamine receptor H1-related conditions
YANNI JOHN M6 citations83
US8673873B1Mar 18, 2014
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders
YANNI JOHN M1 citations62
US8618278B2Dec 31, 2013
RNAi-mediated inhibition of histamine receptor H1-related conditions
YANNI JOHN M2 citations62
US8865671B2Oct 21, 2014
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
YANNI JOHN M0 citations51
US8541389B2Sep 24, 2013
RNAi-mediated inhibition of tumor necrosis factor α-related conditions
YANNI JOHN M0 citations50
PREC BIOSCIENCES INC
5 patentsUS11384335B2Jul 12, 2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
PREC BIOSCIENCES INC1 citations73
US11186822B2Nov 30, 2021
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
PREC BIOSCIENCES INC1 citations73
US11453861B2Sep 27, 2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
PREC BIOSCIENCES INC1 citations70
US11008548B2May 18, 2021
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
PREC BIOSCIENCES INC2 citations70
US11851680B2Dec 26, 2023
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
PREC BIOSCIENCES INC0 citations60
ARROWHEAD PHARMACEUTICALS INC
4 patentsUS10138483B2Nov 27, 2018
Transferrin/transferrin receptor-mediated siRNA delivery
ARROWHEAD PHARMACEUTICALS INC0 citations52
US9932584B2Apr 3, 2018
Interfering RNA delivery system and uses thereof
ARROWHEAD PHARMACEUTICALS INC0 citations52
US9765340B2Sep 19, 2017
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders
ARROWHEAD PHARMACEUTICALS INC0 citations52
US9752147B2Sep 5, 2017
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
ARROWHEAD PHARMACEUTICALS INC0 citations52
ALCON INC
2 patentsCLARK ABBOT F
2 patentsShowing the top 50 of 54 patents by PatentIndex Score.